Labcorp's 15min chart shows Bollinger Bands Narrowing, Bearish Marubozu signal.

Labcorp's 15-minute chart has exhibited a narrowing of Bollinger Bands and a bearish Marubozu candlestick pattern as of August 28, 2025, at 15:30. This indicates a decrease in the magnitude of stock price fluctuations, suggesting that sellers are currently dominant in the market, and the bearish momentum is likely to persist.

Analysts at Bloomberg have recommended buying Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX), both receiving a Strong Buy consensus rating [1]. Labcorp Holdings has a $297.08 average price target, representing a 6.9% upside, while Abivax SA Sponsored ADR has a $87.17 price target [1].

Labcorp Holdings, a healthcare diagnostics company, has shown significant growth potential. The company has focused on strategic acquisitions and partnerships to drive revenue growth. In the second quarter of 2025, Labcorp invested $25 million in acquisitions and partnerships, contributing 3.5% to revenue growth. Notable acquisitions include Incyte Diagnostics and BioReference Health, enhancing its capabilities in key specialty areas like oncology and women's health [1]. Labcorp's operational efficiency initiatives, such as the LaunchPad program, have also contributed to its financial performance. The company has successfully achieved targeted savings of $350 million by the end of 2024 and aims to drive $100-$125 million in savings each year [1].

Abivax SA Sponsored ADR, a biotechnology company, has also received a positive outlook from analysts. LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Abivax SA Sponsored ADR with a price target of $116.00. The company's shares closed last Friday at $77.28, indicating potential for growth [2].

Both companies have experienced bullish sentiments from analysts, suggesting they are well-positioned for future growth. Investors should closely monitor these companies for potential opportunities.

References:
[1] https://www.ainvest.com/news/analysts-bullish-healthcare-stocks-labcorp-holdings-abivax-sa-sponsored-adr-2508/
[2] https://www.theglobeandmail.com/investing/markets/stocks/LH/pressreleases/34385440/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-abivax-sa-sponsored-adr-abvx/